Management of uterine bleeding by PGs or their synthesis inhibitors.
D000328:Adult; D002260:Carboprost / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors; D004311:Double-Blind Method; D005260:Female; D005439:Flufenamic Acid / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007434:Intrauterine Devices / Q000009:adverse effects*; D010919:Placebos; D011460:Prostaglandins F / Q000494:pharmacology; D014592:Uterine Hemorrhage / Q000188:drug therapy* / Q000209:etiology
D016861:Cyclooxygenase Inhibitors; D010919:Placebos; D011460:Prostaglandins F; D005439:Flufenamic Acid; D002260:Carboprost; D007213:Indomethacin